Showing results (921-930 of 4,553) with videos related to

Sort By:
Pageof 456
Drug Development and Industrial Pharmacy|August 26, 2022
Preparation and evaluation of liposome with ropivacaine ion-pairing in local pain managementPeng Ke, Yaxin Qin, Yeting Shao, et al.
Drug Development and Industrial Pharmacy|September 30, 2021
Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterizationBusra Kandilli, Afife Busra Ugur Kaplan, Meltem Cetin, et al.
Drug Development and Industrial Pharmacy|September 30, 2021
An updated review of mesoporous carbon as a novel drug delivery systemMohamed S Attia, Mohamed Y Hassaballah, Mohab A Abdelqawy, et al.
Drug Development and Industrial Pharmacy|September 30, 2021
Enhancing flowability of fine cohesive active pharmaceutical ingredientsRahul Sharma, Gautam Setia
Drug Development and Industrial Pharmacy|October 4, 2021
Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacologyXian-Wen Ye, Ya-Ling Deng, Xia Zhang, et al.
Drug Development and Industrial Pharmacy|February 23, 2022
The mechanisms of immune-chemotherapy with nanocomplex codelivery of pTRP-2 and adjuvant of paclitaxel against melanomaZhonghua Ji, Jiaojiao Xu, Min Li, et al.
Drug Development and Industrial Pharmacy|February 24, 2022
Crystal engineering of valproic acid and carbamazepine to improve hygroscopicity and dissolution profileSheida Khajir, Ali Shayanfar, Farnaz Monajjemzadeh, et al.
Drug Development and Industrial Pharmacy|April 16, 2019
Central composite rotatable design for optimization of budesonide-loaded cross-linked chitosan-dextran sulfate nanodispersion: characterization, in vitro diffusion and aerodynamic studyDivyanka Shrikant Bodas, Pradum Pundlikrao Ige
Drug Development and Industrial Pharmacy|April 17, 2019
Anti-hyperuricemic property of 6-shogaol via self-micro emulsifying drug delivery system in model rats: formulation design, in vitro and in vivo evaluationQiuxuan Yang, Qilong Wang, Yingshu Feng, et al.
Drug Development and Industrial Pharmacy|April 25, 2019
Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosisMohammad A M Momin, Shubhra Sinha, Ian G Tucker, et al.
Pageof 456